These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21193314)

  • 21. De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.
    Herschhorn A; Lerman L; Weitman M; Gleenberg IO; Nudelman A; Hizi A
    J Med Chem; 2007 May; 50(10):2370-84. PubMed ID: 17458947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
    Di Santo R; Costi R; Artico M; Miele G; Lavecchia A; Novellino E; Bergamini A; Cancio R; Maga G
    ChemMedChem; 2006 Dec; 1(12):1367-78. PubMed ID: 17089433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel HIV-1 reverse transcriptase inhibitors.
    Jochmans D
    Virus Res; 2008 Jun; 134(1-2):171-85. PubMed ID: 18308412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach.
    Distinto S; Esposito F; Kirchmair J; Cardia MC; Gaspari M; Maccioni E; Alcaro S; Markt P; Wolber G; Zinzula L; Tramontano E
    Eur J Med Chem; 2012 Apr; 50():216-29. PubMed ID: 22361685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
    Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
    Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides.
    Hang JQ; Rajendran S; Yang Y; Li Y; In PW; Overton H; Parkes KE; Cammack N; Martin JA; Klumpp K
    Biochem Biophys Res Commun; 2004 Apr; 317(2):321-9. PubMed ID: 15063760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Billamboz M; Bailly F; Barreca ML; De Luca L; Mouscadet JF; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2008 Dec; 51(24):7717-30. PubMed ID: 19053754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
    Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
    J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Distinto S; Corona A; Bianco G; Cannas V; Esposito F; Artese A; Alcaro S; Matyus P; Bogdan D; Cottiglia F; Tramontano E; Maccioni E
    Eur J Med Chem; 2015 Mar; 93():452-60. PubMed ID: 25728026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV-1 ribonuclease H activity by novel frangula-emodine derivatives.
    Tatyana K; Francesca E; Luca Z; Giovanni F; Cheng YC; Ginger ED; Enzo T
    Med Chem; 2009 Sep; 5(5):398-410. PubMed ID: 19534674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
    Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R
    ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
    Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
    Cuzzucoli Crucitti G; Métifiot M; Pescatori L; Messore A; Madia VN; Pupo G; Saccoliti F; Scipione L; Tortorella S; Esposito F; Corona A; Cadeddu M; Marchand C; Pommier Y; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2015 Feb; 58(4):1915-28. PubMed ID: 25629256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
    Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
    J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argentine plant extracts active against polymerase and ribonuclease H activities of HIV-1 reverse transcriptase.
    Hnatyszyn O; Broussalis A; Herrera G; Muschietti L; Coussio J; Martino V; Ferraro G; Font M; Monge A; Martínez-Irujo JJ; Sanromán M; Cuevas MT; Santiago E; Lasarte JJ
    Phytother Res; 1999 May; 13(3):206-9. PubMed ID: 10353158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.
    Esposito F; Tramontano E
    Antivir Chem Chemother; 2014 Jan; 23(4):129-44. PubMed ID: 24150519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptase.
    Nakayama GR; Bingham P; Tan D; Maegley KA
    Anal Biochem; 2006 Apr; 351(2):260-5. PubMed ID: 16527235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure of the RNase H domain of the HIV-1 reverse transcriptase in the presence of magnesium.
    Pari K; Mueller GA; DeRose EF; Kirby TW; London RE
    Biochemistry; 2003 Jan; 42(3):639-50. PubMed ID: 12534276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.